# Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints

> **NCT02260947** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06273340
- **DRUG:** PF-06273340
- **DRUG:** Pregabalin
- **DRUG:** Ibuprofen
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02260947
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02260947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02260947, "Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02260947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*